United Kingdom

People: Simulations Plus Inc (SLP.OQ)

SLP.OQ on NASDAQ Stock Exchange Capital Market

16 Aug 2019
Change (% chg)

$0.83 (+2.26%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Grasela, Thaddeus 

Dr. Thaddeus Henry Grasela is President of the Company. Mr. GRASELA has been President and a Director of the Company since the Company acquired Cognigen Corporation (“Cognigen”) also known as the Buffalo Division of the Company, on September 2, 2014. He was the founder, President and Chief Executive Officer of Cognigen for 22 years prior to the acquisition, and continues to serve as its President. Dr. Grasela has had extensive experience in the strategic oversight of scientific consulting projects, promoting new revenue generation, managing profitability, and overseeing the growth of the organization. He is a Fellow of the American Association of Pharmaceutical Scientists and Adjunct Professor in the Department of Pharmaceutical Sciences at the State University of New York at Buffalo. He received his PharmD in 1979 from the Philadelphia College of Pharmacy and Science and his doctorate in Epidemiology from the University at Buffalo in 1999. Dr. Grasela’s knowledge of the pharmaceutical industry and his experience running Cognigen makes him a qualified candidate for the Board.

Basic Compensation

Total Annual Compensation, USD 275,000
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 10,000
Fiscal Year Total, USD 285,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --